Bone marrow deficient in IFN-{gamma} signaling selectively reverses GVHD-associated immunosuppression and enhances a tumor-specific GVT effect.
about
Absence of STAT1 in donor-derived plasmacytoid dendritic cells results in increased STAT3 and attenuates murine GVHDExtracorporeal photopheresis attenuates murine graft-versus-host disease via bone marrow-derived interleukin-10 and preserves responses to dendritic cell vaccinationIndoleamine 2,3-dioxygenase in human hematopoietic stem cell transplantation.Absence of Stat1 in donor CD4⁺ T cells promotes the expansion of Tregs and reduces graft-versus-host disease in miceChallenges and opportunities of allogeneic donor-derived CAR T cellsSingle-Agent Post-Transplantation Cyclophosphamide as Graft-versus-Host Disease Prophylaxis after Human Leukocyte Antigen-Matched Related Bone Marrow Transplantation for Pediatric and Young Adult Patients with Hematologic Malignancies.Murine allogeneic CD19 CAR T cells harbor potent antileukemic activity but have the potential to mediate lethal GVHD.Graft-versus-host disease impairs vaccine responses through decreased CD4+ and CD8+ T cell proliferation and increased perforin-mediated CD8+ T cell apoptosis.Minor antigen distribution predicts site-specific graft-versus-tumor activity of adoptively transferred, minor antigen-specific CD8 T Cells.Highlights of the second international conference on "Immunotherapy in Pediatric Oncology".Differential gene expression in acute lymphoblastic leukemia cells surviving allogeneic transplant.
P2860
Q34209366-1CA1D03C-C891-4457-9F9D-B40B3D236075Q34927696-416A9813-E8FD-4A53-A8F4-9D5F3AF6AA21Q35366857-3DBF616C-AC29-4012-A5A5-E9651BA8E10AQ35572384-48198D7E-1CF9-4F85-BBD8-88D80CA001E8Q36257036-C463B031-660F-48E3-8C17-6DC7E9DAF926Q36445665-415C9BB5-855A-452B-88E4-3F1CD82B6F75Q36675086-A9CBFBAB-7291-468F-A990-7AB792B2704AQ36765387-1B812386-36BB-4EAE-99E7-BE914BD39557Q37719395-00644189-1856-4AD6-861D-E71CD8139066Q37919880-32A98A76-DB1D-4039-8AC0-2EE3743C449DQ53314592-68642896-D489-42D5-8AC7-34DB4EAB1984
P2860
Bone marrow deficient in IFN-{gamma} signaling selectively reverses GVHD-associated immunosuppression and enhances a tumor-specific GVT effect.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Bone marrow deficient in IFN-{ ...... s a tumor-specific GVT effect.
@en
Bone marrow deficient in IFN-{ ...... s a tumor-specific GVT effect.
@nl
type
label
Bone marrow deficient in IFN-{ ...... s a tumor-specific GVT effect.
@en
Bone marrow deficient in IFN-{ ...... s a tumor-specific GVT effect.
@nl
prefLabel
Bone marrow deficient in IFN-{ ...... s a tumor-specific GVT effect.
@en
Bone marrow deficient in IFN-{ ...... s a tumor-specific GVT effect.
@nl
P2093
P2860
P1433
P1476
Bone marrow deficient in IFN-{ ...... es a tumor-specific GVT effect
@en
P2093
Crystal L Mackall
Matthew Milliron
Miriam R Anver
Sarah Herby
Terry J Fry
P2860
P304
P356
10.1182/BLOOD-2008-11-187385
P407
P577
2009-03-03T00:00:00Z